Literature DB >> 23683462

Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3.

Ilkka S Junttila1, Cynthia Watson2, Laura Kummola3, Xi Chen2, Jane Hu-Li2, Liying Guo2, Ryoji Yagi2, William E Paul4.   

Abstract

BACKGROUND: IL-13 is a critical effector cytokine for allergic inflammation. It is produced by several cell types, including mast cells, basophils, and TH2 cells. In mast cells and basophils its induction can be stimulated by cross-linkage of immunoglobulin receptors or cytokines. The IL-1 family members IL-33 and IL-18 have been linked to induction of IL-13 production by mast cells and basophils. In CD4 TH2 cells IL-33-mediated production of IL-13 requires simultaneous signal transducer and activator of transcription (STAT) 5 activation.
OBJECTIVE: Here we have addressed whether cytokine-induced IL-13 production in mast cells and basophils follows the same logic as in TH2 cells: requirement of 2 separate signals.
METHODS: By generating a bacterial artificial chromosome (BAC) transgenic IL-13 reporter mouse, we measured IL-13 production in mast cells and basophils.
RESULTS: In mast cells harvested from peritoneal cavities, 2 cytokine signals are required for IL-13 production: IL-33 and IL-3. In bone marrow mast cells IL-13 production requires IL-33, but the requirement for a STAT5 inducer is difficult to evaluate because these cells require the continuous presence of IL-3 (a STAT5 activator) for survival. Poorer STAT5 inducers in culture (IL-4 or stem cell factor) result in less IL-13 production on IL-33 challenge, but the addition of exogenous IL-3 enhances IL-13 production. This implies that bone marrow-derived mast cells, like peritoneal mast cells and TH2 cells, require stimulation both by an IL-1 family member and a STAT5 inducer to secrete IL-13. Basophils follow the same rule; splenic basophils produce IL-13 in response to IL-18 or IL-33 plus IL-3.
CONCLUSION: Optimal IL-13 production from mast cells and basophils requires 2 cytokine signals. Published by Mosby, Inc.

Entities:  

Keywords:  BAC; BAC transgenic mouse; BMMC; Bacterial artificial chromosome; Bone marrow–derived mast cell; DsRed fluorochrome; IL-18 receptor; IL-18R; Mast cells; SCF; STAT; Signal transducer and activator of transcription; Stem cell factor; WT; Wild-type; allergic inflammation; basophils; cytokines; signal transducer and activator of transcription 5; tyrosine phosphorylation

Mesh:

Substances:

Year:  2013        PMID: 23683462      PMCID: PMC3782850          DOI: 10.1016/j.jaci.2013.03.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  22 in total

1.  IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.

Authors:  T Yoshimoto; H Tsutsui; K Tominaga; K Hoshino; H Okamura; S Akira; W E Paul; K Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events.

Authors:  Peter O Krutzik; Garry P Nolan
Journal:  Cytometry A       Date:  2003-10       Impact factor: 4.355

3.  Stat5 expression is critical for mast cell development and survival.

Authors:  Christopher P Shelburne; Margaret E McCoy; Roland Piekorz; Veronica Sexl; Kwan-Ho Roh; Sarah M Jacobs-Helber; Sheila R Gillespie; Daniel P Bailey; Paria Mirmonsef; Meredith N Mann; Mohit Kashyap; Harry V Wright; Hey Jin Chong; L Andrew Bouton; Brian Barnstein; Carlos D Ramirez; Kevin D Bunting; Steven Sawyer; Chris S Lantz; John J Ryan
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

4.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

5.  Interleukin-13: central mediator of allergic asthma.

Authors:  M Wills-Karp; J Luyimbazi; X Xu; B Schofield; T Y Neben; C L Karp; D D Donaldson
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

6.  Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells.

Authors:  H Toru; R Pawankar; C Ra; J Yata; T Nakahata
Journal:  J Allergy Clin Immunol       Date:  1998-09       Impact factor: 10.793

Review 7.  Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites.

Authors:  Fred D Finkelman; Terez Shea-Donohue; Suzanne C Morris; Lucy Gildea; Richard Strait; Kathleen B Madden; Lisa Schopf; Joseph F Urban
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

Review 8.  Cytokine-induced cytokine production by conventional and innate lymphoid cells.

Authors:  Liying Guo; Ilkka S Junttila; William E Paul
Journal:  Trends Immunol       Date:  2012-09-05       Impact factor: 16.687

9.  Simple and highly efficient BAC recombineering using galK selection.

Authors:  Søren Warming; Nina Costantino; Donald L Court; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

10.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

Authors:  D B Corry; H G Folkesson; M L Warnock; D J Erle; M A Matthay; J P Wiener-Kronish; R M Locksley
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

2.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

Authors:  Emma Lefrançais; Anais Duval; Emilie Mirey; Stéphane Roga; Eric Espinosa; Corinne Cayrol; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 3.  The differential expression of IL-4 and IL-13 and its impact on type-2 immunity.

Authors:  Katherine Bao; R Lee Reinhardt
Journal:  Cytokine       Date:  2015-06-11       Impact factor: 3.861

4.  Allergen-Induced CD4+ T Cell Cytokine Production within Airway Mucosal Dendritic Cell-T Cell Clusters Drives the Local Recruitment of Myeloid Effector Cells.

Authors:  Tibor Z Veres; Tamás Kopcsányi; Nicholas van Panhuys; Michael Y Gerner; Zhiduo Liu; Pia Rantakari; Johannes Dunkel; Masayuki Miyasaka; Marko Salmi; Sirpa Jalkanen; Ronald N Germain
Journal:  J Immunol       Date:  2016-11-30       Impact factor: 5.422

Review 5.  New insights into basophil heterogeneity.

Authors:  Landon K Oetjen; Mario Noti; Brian S Kim
Journal:  Semin Immunopathol       Date:  2016-05-13       Impact factor: 9.623

Review 6.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

7.  Skin exposure promotes a Th2-dependent sensitization to peanut allergens.

Authors:  Leticia Tordesillas; Ritobrata Goswami; Sara Benedé; Galina Grishina; David Dunkin; Kirsi M Järvinen; Soheila J Maleki; Hugh A Sampson; M Cecilia Berin
Journal:  J Clin Invest       Date:  2014-10-08       Impact factor: 14.808

Review 8.  Interferon at the crossroads of allergy and viral infections.

Authors:  Sarah R Gonzales-van Horn; J David Farrar
Journal:  J Leukoc Biol       Date:  2015-05-29       Impact factor: 4.962

9.  Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.

Authors:  Na-Ra Han; Hee-Yun Kim; Soonsik Kang; Mi Hye Kim; Kyoung Wan Yoon; Phil-Dong Moon; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

10.  ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.

Authors:  Hadi Maazi; Nisheel Patel; Ishwarya Sankaranarayanan; Yuzo Suzuki; Diamanda Rigas; Pejman Soroosh; Gordon J Freeman; Arlene H Sharpe; Omid Akbari
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.